Correlation between the severity of cetuximab-induced skin rash and clinical outcome for head and neck cancer patients: The XXXX experience

Similar Items

• Integrating Biologically Targeted Therapy in Head and Neck Squamous Cell Carcinomas
  od: Le, Quynh-Thu, i dr.
  Izdano: (2009)
• Quality of life and performance status from a sub-study conducted within a prospective phase III randomized trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for locally advanced head and neck carcinoma: NRG Oncology RTOG 0522
  od: Truong, Minh Tam, i dr.
  Izdano: (2016)
• Metabolic Tumor Volume as a Prognostic Imaging-Based Biomarker for Head and Neck Cancer—Pilot Results from RTOG 0522
  od: Schwartz, David L., i dr.
  Izdano: (2015)
• p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma
  od: Chung, Christine H., i dr.
  Izdano: (2014)
• Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
  od: Bonner, James A., i dr.
  Izdano: (2016)